pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$TARAProtara Therapeutics, Inc.

$TARA
New York, NY, USupdated 3mo ago
Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
2
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(2)

pipeline depth2 products
Phase 2: 1Phase 3: 1
1Phase 21Phase 3
Phase 3
choline chloride
Liver Diseases
Phase 2
TARA-002
Unspecified Rare Disease

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase2Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancerrecruitingn=131
  • phase3Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Supportrecruitingn=129
  • phase3Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancernot yet recruitingn=284
  • phase2Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Agerecruitingn=38
  • phase1Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)completedn=10
  • phase1Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)completedn=12
  • —Prevalence of Liver Disease in Patients Dependent on Parenteral Nutritioncompletedn=80
🐶 Hiring Signal
No open roles indexed yet — view Protara Therapeutics, Inc. jobs →

News

  • BioSpace 2027 Best Places to Work shines light on most admired employers
    The list honors 50 life sciences employers of choice. Employees at SERB Pharmaceuticals and CSL Behring share why their companies stand out.
    biospace · 7d ago
  • The persisting paradox of men’s health
    A new series in The Lancet argues for the need to investigate a paradox of men’s health: why men experience worse health outcomes than women, even though they hold undeniable…
    stat · 17d ago
  • Setara gets $90M to continue rare disease pipeline spun out of Jazz's Actio deal
    After shipping its precision epilepsy drug to Jazz Pharmaceuticals, Actio Biosciences has spun out the remainder of its genetics-driven pipeline into a new company called Setara Biosciences. Setara…
    endpoints · 18d ago
  • STAT+: How a simple UTI turns into a $1,756 bill
    They visited for what they thought were obvious urgent care issues — coughs, congestion, flu — and were shocked to get bills for ER care instead, totaling thousands of dollars.
    stat · 18d ago
  • Chutes & Ladders—Lilly unifies global markets as 36-year vet Patrik Jonsson retires
    Lilly will unite its U.S. and international commercial units as a long-time exec retires. Enanta's CEO will hang up his hat after 23 year at the helm. Estrella has tapped a new a CEO to lead it thr…
    fiercebiotech · 18d ago
  • STAT+: Nonprofit Bon Secours Mercy Health strikes $5.7 billion deal for surgery center chain
    The deal would make the Catholic system one of the largest operators of outpatient surgery centers.
    stat · 21d ago
  • STAT+: Rising premiums, a sad Medicaid gathering, and a new fraud crackdown
    The cost of health insurance is surging, and CMS presses ahead with a new fraud crackdown.
    stat · 21d ago
  • Health insurance premiums jump 9%, and more Americans don’t have access to coverage
    Working-age U.S. adults without health insurance rose in 2026. Half of all uninsured people did not seek needed care because of cost concerns, according to a new survey.
    stat · 25d ago
  • STAT+: Workers are paying 9% more for family health coverage this year, a higher jump than in the recent past
    A KFF survey finds that rising healthcare costs are squeezing both employers and workers.
    stat · 26d ago
  • STAT+: CMS extends fraud crackdown to New York’s adult day care program
    CMS is cracking down on adult day cares in New York, part of a broader focus on alleged health care fraud.
    stat · 26d ago
view all news mentions →
identifiers
ticker
$TARA
SEC CIK
0001359931
country
US
source
sec_tickers
top tags
Oncology1
mentioned in
10news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 44m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?